FDA Registrations and Clearances since 2009
Vivos System Insurance Reimbursement
Extensive Training and Support Systems
We are a medical technology company focused on the development and commercialization of innovative solutions for patients with sleep disordered breathing (SDB), including obstructive sleep apnea (OSA). We develop and market a number of specially-designed, customized and pre-formed oral appliances, which are integrated into a patient-specific, multi-disciplinary clinical protocol that is used by trained dental and medical providers to address certain craniofacial conditions associated with SDB and OSA. We refer to our proprietary and novel combination of products and protocols as the Vivos System. Our clinical education and training is delivered via online and in-person training through our Institute for Craniofacial Sleep Medicine.
The Vivos System combines both patented and proprietary technologies that induce the remodeling of hard and soft tissues of the human airway – a process that we believe opens airway space and can eliminate or significantly reduce symptoms and conditions associated with OSA. The Vivos System technology represents the first non-surgical, non-invasive and cost-effective solution for the hundreds of millions of people globally who suffer from OSA. The Vivos System combines a customized oral appliance with a propriety therapeutic protocol to gently remodel and enhance the size, shape, and function of the airway by mimicking biological processes (a process known as biomimetics). The Vivos System has been shown to significantly lower Apnea Hypopnea Index (or AHI) scores and improve other conditions associated with OSA. Our patented oral appliances have proven effective (within the scope of the U.S. Food and Drug Administration (or FDA) cleared uses as described below) in over 15,000 patients successfully treated worldwide by more than 1,200 trained dentists.
Latest Stock Information
Latest SEC Filings
Vivos Therapeutics Launches AireO2 Patient Management Technology to Treat Patients with Obstructive Sleep Apnea
Obstructive Sleep Apnea is One of the Most Prevalent Diseases in the World, Affecting Approximately 1 Billion People and Contributing to Serious Comorbidities
Investor Relations Contacts
Vivos Therapeutics, Inc.
9135 S Ridgeline Blvd
Highlands Ranch, CO
SVP, Capital Markets
9137 S Ridgeline Blvd
Highlands Ranch, CO
Phil Carlson / Scott Eckstein
KCSA Strategic Communications